Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 345

1.

[Drug treatment of heart failure in chronic kidney disease].

Marx N.

Internist (Berl). 2019 Oct 30. doi: 10.1007/s00108-019-00691-1. [Epub ahead of print] Review. German.

PMID:
31690996
2.
3.

Heart failure: an underestimated therapeutic target in diabetes.

Marx N.

Cardiovasc Endocrinol Metab. 2018 Feb 14;7(1):10-12. doi: 10.1097/XCE.0000000000000138. eCollection 2018 Mar. Review.

4.

Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarction.

Kahles F, Rückbeil MV, Mertens RW, Foldenauer AC, Arrivas MC, Moellmann J, Lebherz C, Biener M, Giannitsis E, Katus HA, Marx N, Lehrke M.

Eur Heart J. 2019 Oct 16. pii: ehz728. doi: 10.1093/eurheartj/ehz728. [Epub ahead of print]

PMID:
31620788
5.

Editorial: New Trends in Vascular Inflammation Research: From Biology to Therapy.

Aikawa M, Manabe I, Marx N.

Front Cardiovasc Med. 2019 Aug 28;6:102. doi: 10.3389/fcvm.2019.00102. eCollection 2019. No abstract available.

6.

Intrinsic calcification angle: a novel feature of the vulnerable coronary plaque in patients with type 2 diabetes: an optical coherence tomography study.

Reith S, Milzi A, Lemma ED, Dettori R, Burgmaier K, Marx N, Burgmaier M.

Cardiovasc Diabetol. 2019 Sep 24;18(1):122. doi: 10.1186/s12933-019-0926-x.

7.

Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial.

Rosenstock J, Kahn SE, Johansen OE, Zinman B, Espeland MA, Woerle HJ, Pfarr E, Keller A, Mattheus M, Baanstra D, Meinicke T, George JT, von Eynatten M, McGuire DK, Marx N; CAROLINA Investigators.

JAMA. 2019 Sep 19. doi: 10.1001/jama.2019.13772. [Epub ahead of print]

PMID:
31536101
8.

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, Huikuri HV, Johansson I, Jüni P, Lettino M, Marx N, Mellbin LG, Östgren CJ, Rocca B, Roffi M, Sattar N, Seferović PM, Sousa-Uva M, Valensi P, Wheeler DC; ESC Scientific Document Group .

Eur Heart J. 2019 Aug 31. pii: ehz486. doi: 10.1093/eurheartj/ehz486. [Epub ahead of print] No abstract available.

PMID:
31497854
9.

Incidence and predictors of pacemaker induced cardiomyopathy: A single-center experience.

Abdin A, Yalin K, Zink MD, Napp A, Gramlich M, Marx N, Schuett K.

J Electrocardiol. 2019 Aug 23;57:31-34. doi: 10.1016/j.jelectrocard.2019.08.016. [Epub ahead of print]

PMID:
31473477
10.

Speckle Tracking Echocardiography and All-Cause and Cardiovascular Mortality Risk in Chronic Kidney Disease Patients.

Jahn L, Kramann R, Marx N, Floege J, Becker M, Schlieper G.

Kidney Blood Press Res. 2019;44(4):690-703. doi: 10.1159/000501225. Epub 2019 Aug 15.

11.

Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach.

Gajjala PR, Bruck H, Noels H, Heinze G, Ceccarelli F, Kribben A, Saez-Rodriguez J, Marx N, Zidek W, Jankowski J, Jankowski V.

J Mol Med (Berl). 2019 Oct;97(10):1451-1463. doi: 10.1007/s00109-019-01823-8. Epub 2019 Aug 5.

12.

Novel Promoters Derived from Chinese Hamster Ovary Cells via In Silico and In Vitro Analysis.

Nguyen LN, Baumann M, Dhiman H, Marx N, Schmieder V, Hussein M, Eisenhut P, Hernandez I, Koehn J, Borth N.

Biotechnol J. 2019 Nov;14(11):e1900125. doi: 10.1002/biot.201900125. Epub 2019 Aug 9.

PMID:
31271264
13.

Hemodynamic support with Impella ventricular assist device in patients undergoing TAVI: A single center experience.

Almalla M, Kersten A, Altiok E, Marx N, Schröder JW.

Catheter Cardiovasc Interv. 2019 Jul 3. doi: 10.1002/ccd.28375. [Epub ahead of print]

PMID:
31268621
14.

[Dizziness - Differential Diagnosis and Therapy of a Common Symptom in Clinical Routine].

Marx N.

Dtsch Med Wochenschr. 2019 Jun;144(12):781. doi: 10.1055/a-0650-1866. Epub 2019 Jun 18. German. No abstract available.

PMID:
31212320
15.

Significance of psychosocial factors in cardiology: update 2018 : Position paper of the German Cardiac Society.

Albus C, Waller C, Fritzsche K, Gunold H, Haass M, Hamann B, Kindermann I, Köllner V, Leithäuser B, Marx N, Meesmann M, Michal M, Ronel J, Scherer M, Schrader V, Schwaab B, Weber CS, Herrmann-Lingen C.

Clin Res Cardiol. 2019 Nov;108(11):1175-1196. doi: 10.1007/s00392-019-01488-w. Epub 2019 May 10. Review.

PMID:
31076853
16.

In Reply.

Altiok E, Marx N.

Dtsch Arztebl Int. 2019 Mar 29;116(13):221. doi: 10.3238/arztebl.2019.0221a. No abstract available.

17.

[Heart failure and diabetes-underestimated, poorly understood and too rarely diagnosed].

Marx N, Dörr R, Tschöpe D.

Herz. 2019 May;44(3):189-191. doi: 10.1007/s00059-019-4797-4. German. No abstract available.

PMID:
31053890
18.

Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk.

Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JFE, Mancia G, Redon J, Schmieder RE, Marx N, Sliwa K, Weber MA, Williams B, Yusuf S.

Eur Heart J. 2019 Jul 1;40(25):2032-2043. doi: 10.1093/eurheartj/ehz149.

PMID:
30919899
19.

Cardiac FGF23: new insights into the role and function of FGF23 after acute myocardial infarction.

Schumacher D, Alampour-Rajabi S, Ponomariov V, Curaj A, Wu Z, Staudt M, Rusu M, Jankowski V, Marx N, Jankowski J, Brandenburg V, Liehn EA, Schuh A.

Cardiovasc Pathol. 2019 May - Jun;40:47-54. doi: 10.1016/j.carpath.2019.02.001. Epub 2019 Feb 10.

PMID:
30852297
20.

Heart failure and diabetes: management and open issues.

Schütt K, Marx N.

Herz. 2019 May;44(3):203-209. doi: 10.1007/s00059-019-4792-9.

PMID:
30847507
21.

A novel transcatheter aortic valve with a form-fitting anchor for self-alignment: feasibility in a chronic preclinical model.

Noterdaeme T, Marx N, Lange R.

Interact Cardiovasc Thorac Surg. 2019 Jul 1;29(1):8-14. doi: 10.1093/icvts/ivz005.

PMID:
30768173
22.

FDA guidance on antihyperglyacemic therapies for type 2 diabetes: One decade later.

McGuire DK, Marx N, Johansen OE, Inzucchi SE, Rosenstock J, George JT.

Diabetes Obes Metab. 2019 May;21(5):1073-1078. doi: 10.1111/dom.13645. Epub 2019 Mar 12.

PMID:
30690856
23.

Cardiovascular Benefits of GLP-1 Receptor Agonism: Is Inflammation a Key?

Marx N, Libby P.

JACC Basic Transl Sci. 2018 Dec 31;3(6):858-860. doi: 10.1016/j.jacbts.2018.11.008. eCollection 2018 Dec. No abstract available.

24.

Oral Anticoagulation.

Altiok E, Marx N.

Dtsch Arztebl Int. 2018 Nov 16;115(46):776-783. doi: 10.3238/arztebl.2018.0776. Review.

25.

Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials.

Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Ukena C, Mann JFE, Mancia G, Redon J, Schmieder RE, Sliwa K, Marx N, Weber MA, Williams B, Yusuf S.

Eur Heart J. 2018 Dec 24. doi: 10.1093/eurheartj/ehy808. [Epub ahead of print]

PMID:
30590564
26.

Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.

McGuire DK, Alexander JH, Johansen OE, Perkovic V, Rosenstock J, Cooper ME, Wanner C, Kahn SE, Toto RD, Zinman B, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George JT, von Eynatten M, Marx N; CARMELINA Investigators.

Circulation. 2019 Jan 15;139(3):351-361. doi: 10.1161/CIRCULATIONAHA.118.038352.

PMID:
30586723
27.

AnnexinA5-pHrodo: a new molecular probe for measuring efferocytosis.

Stöhr R, Deckers N, Schurgers L, Marx N, Reutelingsperger CP.

Sci Rep. 2018 Dec 7;8(1):17731. doi: 10.1038/s41598-018-35995-z.

28.

Development of the Metabolic Syndrome: Study Design and Baseline Data of the Lufthansa Prevention Study (LUPS), A Prospective Observational Cohort Survey.

Müller-Wieland D, Altenburg C, Becher H, Burchard J, Frisch A, Gebhard J, Haas J, Harth V, Heeren J, Hengelbrock J, von Karais M, Knebel B, Kotzka J, Löwe B, Marx N, Pinnschmidt H, Preisser A, Rose M, Sawitzky-Rose B, Scheja L, Terschüren C, Töller M, Vettorazzi E, Wegscheider K.

Exp Clin Endocrinol Diabetes. 2018 Nov 26. doi: 10.1055/a-0767-6361. [Epub ahead of print]

PMID:
30477037
29.

Empagliflozin Increases Cardiac Energy Production in Diabetes: Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors.

Verma S, Rawat S, Ho KL, Wagg CS, Zhang L, Teoh H, Dyck JE, Uddin GM, Oudit GY, Mayoux E, Lehrke M, Marx N, Lopaschuk GD.

JACC Basic Transl Sci. 2018 Aug 26;3(5):575-587. doi: 10.1016/j.jacbts.2018.07.006. eCollection 2018 Oct.

30.

Hyperkalaemia in Heart Failure-Pathophysiology, Implications and Therapeutic Perspectives.

Llubani R, Vukadinović D, Werner C, Marx N, Zewinger S, Böhm M.

Curr Heart Fail Rep. 2018 Dec;15(6):390-397. doi: 10.1007/s11897-018-0413-9. Review.

PMID:
30421355
31.

Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.

Rosenstock J, Perkovic V, Johansen OE, Cooper ME, Kahn SE, Marx N, Alexander JH, Pencina M, Toto RD, Wanner C, Zinman B, Woerle HJ, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George JT, von Eynatten M, McGuire DK; CARMELINA Investigators.

JAMA. 2019 Jan 1;321(1):69-79. doi: 10.1001/jama.2018.18269.

32.

[Pacemaker and ICD-Therapy - Relevant to the Non-Cardiologist].

Marx N.

Dtsch Med Wochenschr. 2018 Nov;143(22):1585. doi: 10.1055/a-0560-3240. Epub 2018 Oct 30. German. No abstract available.

PMID:
30376681
33.

Co-localization of plaque macrophages with calcification is associated with a more vulnerable plaque phenotype and a greater calcification burden in coronary target segments as determined by OCT.

Burgmaier M, Milzi A, Dettori R, Burgmaier K, Marx N, Reith S.

PLoS One. 2018 Oct 24;13(10):e0205984. doi: 10.1371/journal.pone.0205984. eCollection 2018.

34.

Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology.

Maack C, Lehrke M, Backs J, Heinzel FR, Hulot JS, Marx N, Paulus WJ, Rossignol P, Taegtmeyer H, Bauersachs J, Bayes-Genis A, Brutsaert D, Bugger H, Clarke K, Cosentino F, De Keulenaer G, Dei Cas A, González A, Huelsmann M, Iaccarino G, Lunde IG, Lyon AR, Pollesello P, Rena G, Riksen NP, Rosano G, Staels B, van Laake LW, Wanner C, Farmakis D, Filippatos G, Ruschitzka F, Seferovic P, de Boer RA, Heymans S.

Eur Heart J. 2018 Dec 21;39(48):4243-4254. doi: 10.1093/eurheartj/ehy596. No abstract available.

35.

SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases.

Wanner C, Marx N.

Diabetologia. 2018 Oct;61(10):2134-2139. doi: 10.1007/s00125-018-4678-z. Epub 2018 Aug 22. Review.

PMID:
30132035
36.

Impact of multidrug-resistant bacteria on outcome in patients with prolonged weaning.

Bickenbach J, Schöneis D, Marx G, Marx N, Lemmen S, Dreher M.

BMC Pulm Med. 2018 Aug 20;18(1):141. doi: 10.1186/s12890-018-0708-3.

37.

Whole-Body Plethysmography and Blood Gas Analysis in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.

Dreher M, Daher A, Keszei A, Marx N, Müller T, Cornelissen C, Brandenburg V.

Respiration. 2019;97(1):24-33. doi: 10.1159/000491096. Epub 2018 Aug 15.

PMID:
30110686
38.

Glucagon-Like Peptide 1 and Its Cleavage Products Are Renoprotective in Murine Diabetic Nephropathy.

Moellmann J, Klinkhammer BM, Onstein J, Stöhr R, Jankowski V, Jankowski J, Lebherz C, Tacke F, Marx N, Boor P, Lehrke M.

Diabetes. 2018 Nov;67(11):2410-2419. doi: 10.2337/db17-1212. Epub 2018 Aug 13.

39.

Cardiovascular protection in type 2 diabetes: Insights from recent outcome trials.

Bailey CJ, Marx N.

Diabetes Obes Metab. 2019 Jan;21(1):3-14. doi: 10.1111/dom.13492. Epub 2018 Sep 7. Review.

PMID:
30091169
40.

Reduced post-operative DPP4 activity associated with worse patient outcome after cardiac surgery.

Noels H, Theelen W, Sternkopf M, Jankowski V, Moellmann J, Kraemer S, Lehrke M, Marx N, Martin L, Marx G, Jankowski J, Goetzenich A, Stoppe C.

Sci Rep. 2018 Aug 7;8(1):11820. doi: 10.1038/s41598-018-30235-w.

41.

Myocardial infarction is sufficient to increase GLP-1 secretion, leading to improved left ventricular contractility and mitochondrial respiratory capacity.

Diebold S, Moellmann J, Kahles F, Haj-Yehia E, Liehn EA, Nickel A, Lebherz C, Maack C, Marx N, Lehrke M.

Diabetes Obes Metab. 2018 Dec;20(12):2911-2918. doi: 10.1111/dom.13472. Epub 2018 Aug 16.

PMID:
30033664
42.

Comprehensive pharmaceutical care to prevent drug-related readmissions of dependent-living elderly patients: a randomized controlled trial.

Lenssen R, Schmitz K, Griesel C, Heidenreich A, Schulz JB, Trautwein C, Marx N, Fitzner C, Jaehde U, Eisert A.

BMC Geriatr. 2018 Jun 4;18(1):135. doi: 10.1186/s12877-018-0814-3.

43.

The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE-/- mice by blocking monocyte/macrophage activation.

Kahles F, Liberman A, Halim C, Rau M, Möllmann J, Mertens RW, Rückbeil M, Diepolder I, Walla B, Diebold S, Burgmaier M, Lebherz C, Marx N, Lehrke M.

Mol Metab. 2018 Aug;14:150-157. doi: 10.1016/j.molmet.2018.05.014. Epub 2018 May 23.

44.

CRISPR-Based Targeted Epigenetic Editing Enables Gene Expression Modulation of the Silenced Beta-Galactoside Alpha-2,6-Sialyltransferase 1 in CHO Cells.

Marx N, Grünwald-Gruber C, Bydlinski N, Dhiman H, Ngoc Nguyen L, Klanert G, Borth N.

Biotechnol J. 2018 Oct;13(10):e1700217. doi: 10.1002/biot.201700217. Epub 2018 Jun 11.

PMID:
29802757
45.

High-Dose Ferric Carboxymaltose in Patients With HFrEF Induces Significant Hypophosphatemia.

Stöhr R, Sandstede L, Heine GH, Marx N, Brandenburg V.

J Am Coll Cardiol. 2018 May 15;71(19):2270-2271. doi: 10.1016/j.jacc.2018.03.448. No abstract available.

46.

Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University.

Marx N, Noels H, Jankowski J, Floege J, Fliser D, Böhm M.

Clin Res Cardiol. 2018 Aug;107(Suppl 2):120-126. doi: 10.1007/s00392-018-1260-0. Epub 2018 May 4. Review.

PMID:
29728829
47.

Predictors for target lesion microcalcifications in patients with stable coronary artery disease: an optical coherence tomography study.

Reith S, Milzi A, Dettori R, Marx N, Burgmaier M.

Clin Res Cardiol. 2018 Sep;107(9):763-771. doi: 10.1007/s00392-018-1243-1. Epub 2018 Apr 13.

PMID:
29654434
48.

The new SFB/TRR219 Research Centre.

Noels H, Boor P, Goettsch C, Hohl M, Jahnen-Dechent W, Jankowski V, Kindermann I, Kramann R, Lehrke M, Linz D, Maack C, Niemeyer B, Roma LP, Schuett K, Speer T, Wagenpfeil S, Werner C, Zewinger S, Böhm M, Marx N, Floege J, Fliser D, Jankowski J.

Eur Heart J. 2018 Mar 21;39(12):975-977. doi: 10.1093/eurheartj/ehy083. No abstract available.

PMID:
29579229
49.

Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk.

Rosenstock J, Perkovic V, Alexander JH, Cooper ME, Marx N, Pencina MJ, Toto RD, Wanner C, Zinman B, Baanstra D, Pfarr E, Mattheus M, Broedl UC, Woerle HJ, George JT, von Eynatten M, McGuire DK; CARMELINA® investigators.

Cardiovasc Diabetol. 2018 Mar 14;17(1):39. doi: 10.1186/s12933-018-0682-3.

50.

Adipose tissue ATGL modifies the cardiac lipidome in pressure-overload-induced left ventricular failure.

Salatzki J, Foryst-Ludwig A, Bentele K, Blumrich A, Smeir E, Ban Z, Brix S, Grune J, Beyhoff N, Klopfleisch R, Dunst S, Surma MA, Klose C, Rothe M, Heinzel FR, Krannich A, Kershaw EE, Beule D, Schulze PC, Marx N, Kintscher U.

PLoS Genet. 2018 Jan 10;14(1):e1007171. doi: 10.1371/journal.pgen.1007171. eCollection 2018 Jan.

Supplemental Content

Support Center